Contents
Chair
Speaker(s)
Programme
Presentation
Chair
Dr. Pravin D. Potdar
Former Head & Chief, Department of Molecular Medicine & Biology, Jaslok Hospital & Research Centre, Mumbai, India.
Chairman, Institutional Ethics Committee (IEC), Dr. A.P.J. Abdul Kalam Educational & Research Centre, Indian Dental Association (IDA), Mumbai, India.
Chairman, Institutional Ethics Committee (IEC), Dr. A.P.J. Abdul Kalam Educational & Research Centre, Indian Dental Association (IDA), Mumbai, India.
Speaker(s)
Dr. Debasmita Dutta
Research Fellow, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Dr. Rekha Pal
Director, Scientific Engagement, Crown Biosciences, USA.
Dr. Lopamudra Das Roy
Founder & President, Breast Cancer Hub, Social Entrepreneur, Keynote Speaker, Distinguished Cancer Scientist, Concord, North Carolina, USA.
Dr. Geetha Manjunath
Founder & CEO of Niramai Health Analytix, Bengaluru, Karnataka, India.
Dr. Harsh Sheth
Assistant professor and Head of Advanced Genomic Technologies Division at FRIGE's Institute of Human Genetics, Ahmedabad, Gujarat, India.
Dr. Manash Paul
Scientist, Principal Investigator, Division of Pulmonary and Critical Care Medicine, University of California, Los Angeles, USA.
Dr. Amrit Kaur Kaler
Consultant, Molecular Pathology, Kokilaben Dhirubhai Ambani Hospital & Research Centre, Mumbai, Maharashtra, India.
Dr. Aloukick Kumar Singh
Former Research Scientist, M.D. Anderson Cancer Centre, Houston, Texas, USA
Presently Scientist, Centre of Stem Cell Research, CMC, Vellore, Tamil Nadu, India.
Presently Scientist, Centre of Stem Cell Research, CMC, Vellore, Tamil Nadu, India.
Dr. Rohidas Arote
Associate Professor, Seoul National University, Seoul, South Korea.
Programme
Programme
- Time (India)
- Speakers
- Topics
- 17:30-17:40
- Pravin D. Potdar
- Welcome Speech and Brief Introduction of JCMT
- 17:40-18:00
- Debasmita Dutta
- Nanoengineered drug delivery systems to target tumor microenvironment: A promising and safe alternative of chemotherapy
- 18:00-18:10
- /
- Discussion
- 18:10-18:30
- Rekha Pal
- Exploring immunotherapies within a novel immune-oncology organoid model
- 18:30-18:40
- /
- Discussion
- 18:40-19:00
- Lopamudra Das Roy
- Connecting Research to Community, Saving Lives
- 19:00-19:10
- /
- Discussion
- 19:10-19:30
- Harsh Sheth
- Diagnostics & Preventive program in hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome in India- A Low Hanging Fruit of Detection
- 19:30-19:40
- /
- Discussion
- 19:40-20:00
- Manash Paul
- Lung Cancer Organoids & Drug Discovery
- 20:00-20:10
- /
- Discussion
- 20:10-20:30
- Aloukick Kumar Singh
- Towards off-the-shelf CAR-T cells
- 20:30-20:40
- /
- Discussion
- 20:40-21:00
- Rohidas Arote
- Development of Multifunctional Nanocarriers for Gene Therapy Applications
- 21:00-21:10
- /
- Discussion
- 21:10-21:30
- Geetha Manjunath
- Latest early detection program in Breast Cancer
- 21:30-21:40
- /
- Discussion
Presentation
Dr. Pravin D. Potdar
Topic: Welcome Speech and Brief Introduction of JCMT
24 0 1
Dr. Debasmita Dutta
Topic: Nanoengineered drug delivery systems to target tumor microenvironment: A promising and safe alternative of chemotherapy
NaN
Dr. Lopamudra Das Roy
Topic: Connecting Research to Community, Saving Lives
NaN
Dr. Harsh Sheth
Topic: Diagnostics & Preventive program in hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome in India- A Low Hanging Fruit of Detection
NaN
Dr. Rekha Pal
Topic: Exploring immunotherapies within a novel immune-oncology organoid model
NaN
Dr. Manash Paul
Topic: Lung Cancer Organoids & Drug Discovery
NaN
Dr. Aloukick Kumar Singh
Topic: Towards off-the-shelf CAR-T cells
NaN
Dr. Rohidas Arote
Topic: Development of Multifunctional Nanocarriers for Gene Therapy Applications
NaN
Dr. Geetha Manjunath
Topic: Latest early detection program in Breast Cancer
NaN
